Ischemic Heart Failure Clinical Trial
Mesenchymal stem cells have capability to differentiate into myocardium, vascular endothelial cell, vascular smooth muscle cell and will be useful for heart regeneration. Adipose tissue is relatively enriched with mesenchymal stem cell compared to bone marrow tissue. In this trial, eligible ischemic heart failure patients will be proceeded intracoronary administration of autologous adipose tissue derived stromal cells by cardiac catheterization.
The population of the ischemic heart failure patients is enormous in Japan and the only radical treatment for them is heart transplantation: however, the number of giving donor is extremely limited. Mesenchymal stem cells have been capable to differentiate into mesodermal-lineage cells as well as endodermal-lineage cells such as myocardial cell. They reside in the mesenchymal tissues such as bone marrows as well as adipose tissues. The latter tissues are relatively enriched with mesenchymal stem cells compared to bone marrow cells. In this study, the ischemic heart failure patients will undergo intracoronary administration of autologous adipose tissue derived stromal cells through cardiac catheterization. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02240940 -
PARACHUTE China Approval Trial
|
N/A | |
| Completed |
NCT00846001 -
Resynchronization Surgery Combined Unified Efficacy
|
Phase 3 | |
| Recruiting |
NCT05566600 -
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
|
Early Phase 1 | |
| Active, not recruiting |
NCT01961726 -
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
|
Phase 1/Phase 2 | |
| Terminated |
NCT00102128 -
Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.
|
Phase 2 | |
| Not yet recruiting |
NCT03491969 -
Clinical Study of Lipoic Acid on Ischemic Heart Failure
|
Phase 4 | |
| Recruiting |
NCT01555320 -
Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure
|
N/A | |
| Recruiting |
NCT02875639 -
A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)
|
Phase 2 | |
| Completed |
NCT02700880 -
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
|
||
| Active, not recruiting |
NCT01643590 -
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
|
Phase 2 | |
| Active, not recruiting |
NCT02115568 -
Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203
|
N/A | |
| Recruiting |
NCT03206593 -
Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure
|
N/A | |
| Not yet recruiting |
NCT06258447 -
CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction
|
N/A |